Please sign in to follow a disease.
Cord clamping delay may boost jaundice risk in At-Risk newborns
NCT ID NCT03741803
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether waiting 60 seconds to clamp the umbilical cord (delayed cord clamping) raises bilirubin levels in newborns whose mothers had a previous child with jaundice needing treatment. Twenty mothers and their babies took part. The goal was to see if delayed clamping increases jaundice risk in these already at-risk infants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If it works, this could help doctors decide the safest way to clamp the cord for babies at risk of jaundice.
- What could go wrong
- This is a very small, completed study with only 20 participants, so results may not apply to all babies. It only measures bilirubin levels, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Nov 2018
- Finished
-
May 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * mothers delivering at 35 weeks or greater * mothers who have had at least 1 previous child that received phototherapy for hyperbilirubinemia * multiple gestations can be included unless the neonate does not meet criteria for delayed cord clamping as described below or due to concerns about safety of delayed cord clamping for timing of delivery of the 2nd twin (ie: 2nd twin requires immediate delivery intervention) Exclusion Criteria: \- Neonates who do not meet criteria for delayed cord clamping (any infant that any provider in the room felt needed evaluation by the neonatal transport team immediately so that the infant would be handed off for resuscitation. If the patient required delivery by cesarean section the delayed cord clamping protocol would be abandoned).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hyperbilirubinemia, neonatal are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single dose of fenofibrate beat phenobarbitone for newborn jaundice?
- Tiny sensors could revolutionize jaundice treatment for newborns
- Could a $10 ruler save newborns from brain damage?
- Can a belly rub help jaundiced babies?
- Simple cover and massage may speed up jaundice treatment in newborns
- Simple cover and massage may speed up jaundice treatment in newborns